Community Bank, N.A. Genmab A/S Transaction History

Community Bank, N.A.

$811 Million
Q3 2025

A detailed history of Community Bank, N.A. transactions in Genmab A/S stock. As of the latest transaction made, Community Bank, N.A. holds 1,523 shares of GMAB stock, worth $46,085. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,523

Holding current value

$46,085

% of portfolio

0.01%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2025 Nov 14, 2025	BUY	$20.3 - $30.67 $30,916 - $46,710	1,523 New	1,523 $46,000
Q3 2022 Oct 28, 2022	BUY	$31.52 - $373.61 $3,246 - $38,481	103 New	103 $3,000

Others Institutions Holding GMAB

# of Institutions

277

Shares Held

62.7M

Call Options Held

58.8K

Put Options Held

10.2K

Orbis Allan Gray LTD Hamilton, D0

11.1M
Shares

$335 Million
1.89% of portfolio
Alliancebernstein L.P. New York, NY

11M
Shares

$331 Million
0.11% of portfolio
Black Rock Inc. New York, NY

5.08M
Shares

$154 Million
0.0% of portfolio
Paradigm Biocapital Advisors LP New York, NY

3.82M
Shares

$115 Million
3.77% of portfolio
Arrowstreet Capital, Limited Partnership Boston, MA

3.64M
Shares

$110 Million
0.08% of portfolio

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $19.9B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Community Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Community Bank, N.A. with notifications on news.

Account